Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatitis B or Carcinoma, Hepatocellular
and you are
between 18 and 70
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to determine whether vitamin D is effective in the prevention of hepatocellular carcinoma in those patients with chronic hepatitis B.

Provided treatments

  • Drug: Vitamin D3
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02779465. The sponsor of the trial is Third Affiliated Hospital, Sun Yat-Sen University and it is looking for 1500 volunteers for the current phase.
Official trial title:
Study of Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B